Senior insider sale
SVP, Comm & Medical Affairs at THERAVANCE BIOPHARMA, INC. — senior position signals high conviction
$433.6K
31.07K shares
What this filing means
FARNUM RHONDA plans to sell 31.07K shares of THERAVANCE BIOPHARMA, INC. valued at approximately $433.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001950047-26-002634
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
31.07K
Shares to sell
$433.6K
Approx. market value
31.07K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
11/20/2022
31.07KTotal acquired31.07K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/20/2022 | Restricted Stock Not Applicable | 31.07K | — |
| Total | 31.07K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
31.07K
Market value
$433.6K
3/16/2026
Total
Units
31.07K
Value
$433.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/16/2026 | 31.07K | $433.6K | NASDAQ | Planned |
| Total | 31.07K | $433.6K | ||